Waystar (NASDAQ:WAY) CEO Matthew Hawkins Sells 60,038 Shares

Waystar Holding Corp. (NASDAQ:WAY) CEO Matthew Hawkins sold 60,038 shares of the firm’s stock in a transaction on Thursday, August 13th. The stock was sold at an average price of $25.01, for a total transaction of $1,501,550.38. Following the sale, the chief executive officer owned 1,835,081 shares in the company, valued at approximately $45,895,375.81. The trade was a 3.17% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Waystar Stock Up 2.2%

Shares of WAY stock traded up $0.54 on Thursday, hitting $25.08. 2,301,045 shares of the stock were exchanged, compared to its average volume of 2,704,600. The firm has a market capitalization of $4.81 billion, a P/E ratio of 35.83, a price-to-earnings-growth ratio of 0.95 and a beta of 0.06. The business has a 50-day moving average of $21.42 and a 200 day moving average of $22.80. The company has a current ratio of 1.85, a quick ratio of 1.85 and a debt-to-equity ratio of 0.36. Waystar Holding Corp. has a fifty-two week low of $17.26 and a fifty-two week high of $41.47.

Waystar (NASDAQ:WAY) last issued its quarterly earnings results on Wednesday, July 29th. The company reported $0.43 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.03. The company had revenue of $319.67 million during the quarter, compared to analysts’ expectations of $316.21 million. Waystar had a net margin of 11.18% and a return on equity of 7.03%. The business’s quarterly revenue was up 18.1% on a year-over-year basis. During the same period last year, the business earned $0.36 EPS. Equities analysts anticipate that Waystar Holding Corp. will post 1.47 EPS for the current year.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the company. Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a $39.00 price objective on shares of Waystar in a research note on Friday, July 31st. Citigroup reaffirmed a “buy” rating on shares of Waystar in a report on Monday, July 20th. Barclays boosted their price target on Waystar from $25.00 to $27.00 and gave the company an “overweight” rating in a research note on Friday, August 7th. KeyCorp reaffirmed an “overweight” rating on shares of Waystar in a report on Friday, July 31st. Finally, Raymond James Financial reaffirmed a “strong-buy” rating and set a $32.00 price target on shares of Waystar in a report on Thursday, April 30th. Three analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $35.00.

Institutional Trading of Waystar

A number of institutional investors have recently bought and sold shares of WAY. Connor Clark & Lunn Investment Management Ltd. bought a new stake in shares of Waystar during the 2nd quarter valued at about $253,000. Ieq Capital LLC acquired a new position in Waystar in the second quarter valued at approximately $852,000. Keebeck Wealth Management acquired a new position in Waystar in the second quarter valued at approximately $321,000. Aurora Investment Counsel bought a new position in shares of Waystar during the 2nd quarter worth approximately $1,765,000. Finally, BlackRock Inc. acquired a new stake in shares of Waystar during the 2nd quarter worth approximately $357,950,000.

About Waystar

Waystar (NASDAQ:WAY) is a leading provider of cloud-based revenue cycle management and payment solutions for healthcare organizations. The company’s unified platform streamlines the entire financial continuum of patient care, from eligibility verification and claim submission to payment reconciliation and patient billing. By automating key processes and improving claim accuracy, Waystar helps providers reduce administrative overhead, accelerate cash flow and enhance overall revenue performance.

At the core of Waystar’s offering is a SaaS-based architecture that integrates seamlessly with existing electronic health record (EHR) systems and payer networks.